Lee & Man Chemical Company Limited (0746.HK)
Kwun Tong, HK
Operating as an investment holding entity, Lee & Man Chemical Company Limited is primarily engaged in the production and distribution of various chemical goods across the People's Republic of China. Its business operations are segmented into two core areas: Chemicals and Property. The chemical portfolio encompasses a wide array of offerings, including caustic soda, chloromethane derivatives, polymers, hydrogen peroxide, fluorochemicals, polytetrafluoroethylene (PTFE), and liquefied chlorine. Furthermore, it supplies specialized products such as styrene acrylic latex surface sizing agents and additives for lithium-ion batteries. Beyond chemicals, the company is also active in property development, sales, and leasing. Originally incorporated as Lee & Man Holding Limited, the company adopted its current name, Lee & Man Chemical Company Limited, in June 2011. Established in 1976, its corporate headquarters are situated in Kwun Tong, Hong Kong.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.88% | -2.35% | -6.91% | -25.16% | -19.37% | -12.60% | +25.82% | -3.98% | +5.77% | +95.73% | +764.15% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-03 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals: +4.0%-5.0% Q4'25: -11.3% (vs Q4'23)
-
EPS growth Chemicals: +11.7%+15.5% ★ Q4'25: -25.0% (vs Q4'23)
-
FCF margin FCF growth · Chemicals: +41.7%+23.1% Q4'25: +6.3% (vs Q4'23)
-
EBIT margin Chemicals: +7.1%+17.8% ★ Q4'25: +15.4% (vs Q4'23)
-
ROIC Chemicals: +3.4%+7.6% ★ Q4'25: +12.0% (vs Q4'23)
-
Share dilution Chemicals: +0.0%+1.6% Q4'25: +1.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.04× Q4'25: 1.21× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.71B
est: 2.91B (-41.4%)
|
1.81B
est: 3.74B (-51.5%)
|
3.48B
est: 2.91B (+19.4%)
|
3.10B
est: 3.74B (-17.2%)
|
5.19B
est: 5.22B (-0.6%)
|
5.87B
est: 5.40B (+8.7%)
|
4.05B
est: 4.43B (-8.5%)
|
3.95B
est: 4.19B (-5.6%)
|
3.75B
est: 4.40B (-14.7%)
|
4.76B
4.76B – 4.76B
+8.2% YoY
|
| EBITDA |
400.30M
est: 670.99M (-40.3%)
|
390.86M
est: 862.32M (-54.7%)
|
975.31M
est: 670.99M (+45.4%)
|
743.82M
est: 862.32M (-13.7%)
|
1.72B
est: 1.20B (+42.8%)
|
1.51B
est: 1.24B (+21.7%)
|
597.02M
est: 1.02B (-41.5%)
|
693.50M
est: 931.71M (-25.6%)
|
753.48M
est: 979.55M (-23.1%)
|
1.06B
1.06B – 1.06B
+8.2% YoY
|
| EBIT |
372.08M
est: 626.41M (-40.6%)
|
364.34M
est: 805.04M (-54.7%)
|
928.67M
est: 626.41M (+48.3%)
|
692.65M
est: 805.04M (-14.0%)
|
1.66B
est: 1.12B (+47.8%)
|
1.44B
est: 1.16B (+23.8%)
|
533.18M
est: 952.15M (-44.0%)
|
614.41M
est: 862.76M (-28.8%)
|
669.65M
est: 907.06M (-26.2%)
|
981.65M
981.65M – 981.65M
+8.2% YoY
|
| Net Income |
269.68M
est: 462.00M (-41.6%)
|
216.20M
est: 561.00M (-61.5%)
|
700.77M
est: 462.00M (+51.7%)
|
502.63M
est: 561.00M (-10.4%)
|
1.29B
est: 965.25M (+33.4%)
|
1.16B
est: 1.05B (+10.4%)
|
400.67M
est: 479.33M (-16.4%)
|
482.28M
est: 502.80M (-4.1%)
|
558.26M
est: 543.03M (+2.8%)
|
610.07M
610.07M – 610.07M
+12.3% YoY
|
| SGA |
213.52M
est: 330.09M (-35.3%)
|
259.99M
est: 424.22M (-38.7%)
|
428.08M
est: 330.09M (+29.7%)
|
424.53M
est: 424.22M (+0.1%)
|
532.48M
est: 591.51M (-10.0%)
|
531.30M
est: 611.80M (-13.2%)
|
468.13M
est: 501.74M (-6.7%)
|
477.74M
est: 461.58M (+3.5%)
|
456.11M
est: 485.28M (-6.0%)
|
525.18M
525.18M – 525.18M
+8.2% YoY
|
| EPS |
0.33
est: 0.56 (-41.1%)
|
0.26
est: 0.68 (-61.8%)
|
0.85
est: 0.56 (+51.8%)
|
0.61
est: 0.68 (-10.3%)
|
1.56
est: 1.17 (+33.3%)
|
1.40
est: 1.27 (+10.2%)
|
0.49
est: 0.58 (-15.7%)
|
0.58
est: 0.60 (-3.3%)
|
0.68
est: 0.65 (+4.9%)
|
0.73
0.73 – 0.73
+12.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-28 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-27 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-26 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-22 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 36.3K | 0.46% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 85.1K | 0.39% |
| 3 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 91.7K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Man Yan Lee | Group Chief Executive Officer & Executive Director | 11M | male |
| Siu Kee Wai | Executive Chairman of the Board | 8M | female |
| Zuo Ning Yang | Executive Director | 3M | male |
| Hiu Fung Lam ACIArb FCCA FTIHK HKICPA | Group Financial Controller | — | male |
| Siu Yin Hung | Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0746.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
